The right price : a value-based prescription for drug costs /
The pharmaceutical industry and its pricing methods provide an inviting target, easy to disparage and caricature. Even after accounting for discounts and rebates, average prices of leading brand-name drugs in the US are two to four times higher than they are in Canada, Japan, and many European count...
Saved in:
| Online Access: |
Full text (MCPHS users only) Full text (MCPHS users only) |
|---|---|
| Main Authors: | , , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York, NY :
Oxford University Press,
2021
|
| Subjects: |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | in00000367777 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 201204t20212021nyua ob 001 0 eng | ||
| 005 | 20240910175740.4 | ||
| 010 | |a 2020054439 | ||
| 035 | |a (OCoLC)on1226990832 | ||
| 040 | |a DLC |b eng |e rda |e pn |c DLC |d OCLCO |d OCLCA |d YDX |d OCLCA |d EBLCP |d OCLCO |d UIU |d UAB |d OCLCO |d YDX |d STBDS |d OCLCF |d N$T |d UKAHL |d TFW |d IUL |d K6U |d OCLCO |d OCLCQ |d SFB |d OCLCQ |d OCLCO |d OCLCL | ||
| 020 | |a 9780197512913 |q electronic book | ||
| 020 | |a 0197512917 |q electronic book | ||
| 020 | |a 0197512909 |q electronic book | ||
| 020 | |a 9780197512890 |q electronic book | ||
| 020 | |a 0197512895 |q electronic book | ||
| 020 | |a 9780197512906 |q (electronic bk.) | ||
| 020 | |z 9780197512876 |q paperback | ||
| 020 | |z 9780197512883 |q hardcover | ||
| 029 | 1 | |a AU@ |b 000068403461 | |
| 035 | |a (OCoLC)1226990832 | ||
| 042 | |a pcc | ||
| 043 | |a n-us--- | ||
| 050 | 0 | 4 | |a RA412.3 |b .N48 2021 |
| 060 | 0 | 0 | |a QV 736 AA1 |
| 082 | 0 | 0 | |a 368.38/24 |2 23 |
| 049 | |a MPAA | ||
| 100 | 1 | |a Neumann, Peter J., |d 1961- |e author. | |
| 245 | 1 | 4 | |a The right price : |b a value-based prescription for drug costs / |c Peter J. Neumann, Joshua T. Cohen, and Daniel A. Ollendorf. |
| 264 | 1 | |a New York, NY : |b Oxford University Press, |c [2021] | |
| 264 | 4 | |c ©2021 | |
| 300 | |a 1 online resource (xv, 255 pages) : |b illustrations (some color). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b n |2 rdamedia | ||
| 338 | |a online resource |b nc |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a The prescription drug market -- Proposed solutions for rising drug prices -- Measuring the value of prescription drugs -- Measuring drug value : whose job is it anyway? -- Institute for Clinical and Economic Review (ICER) -- Other US value assessment frameworks -- Do drugs for special populations warrant higher prices? -- Improving value measurement -- Aligning prices with value -- The path forward. | |
| 520 | |a The pharmaceutical industry and its pricing methods provide an inviting target, easy to disparage and caricature. Even after accounting for discounts and rebates, average prices of leading brand-name drugs in the US are two to four times higher than they are in Canada, Japan, and many European countries. US per capita spending on prescription drugs is more than twice the level in the United Kingdom. Prices for most new cancer drugs now exceed $100,000 per patient per year of treatment, despite the fact that many of these treatments seem to offer modest gains in life expectancy or lack such evidence at all. With the advent of ever more targeted and powerful treatments, including cell- and gene-based therapies with multi-million dollar price tags, the need for sensible drug pricing and coverage policies will intensify. | ||
| 588 | |a Description based on online resource; title from digital title page (viewed on May 29, 2021). | ||
| 650 | 0 | |a Prescription pricing |z United States. | |
| 650 | 0 | |a Drugs |x Prices |z United States. | |
| 650 | 0 | |a Pharmaceutical industry |x Economic aspects |z United States. | |
| 650 | 1 | 2 | |a Prescription Fees |0 (DNLM)D011306 |
| 650 | 2 | 2 | |a Drug Costs |0 (DNLM)D016527 |
| 650 | 2 | 2 | |a Prescription Drugs |x economics |0 (DNLM)D055553Q000191 |
| 651 | 2 | |a United States |0 (DNLM)D014481 | |
| 700 | 1 | |a Cohen, Joshua T., |e author. | |
| 700 | 1 | |a Ollendorf, Daniel A., |e author. | |
| 758 | |i has work: |a The right price (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGWwCkV9CFKmB8TBVYtV83 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Neumann, Peter J., 1961- |t The right price |d New York, NY : Oxford University Press, [2021] |z 9780197512876 |w (DLC) 2020054438 |
| 994 | |a C0 |b MPA | ||
| 999 | f | f | |s 69d0b5bc-a671-43b8-85cd-e4beb108b7ff |i 76dc702b-e547-424c-995a-cc3acba727c3 |t 0 |
| 952 | f | f | |p Can circulate |a Massachusetts College of Pharmacy and Health Sciences |b Online |c Online |d E-Collections |t 0 |e Oxford Academic |h Other scheme |i E-Resource |m ereserve240 |
| 856 | 4 | 0 | |t 0 |u https://ezproxymcp.flo.org/login?url=https://doi.org/10.1093/oso/9780197512883.001.0001 |y Full text (MCPHS users only) |
| 856 | 4 | 0 | |t 0 |u https://ezproxymcp.flo.org/login?url=https://doi-org.ezproxymcp.flo.org/10.1093/oso/9780197512883.001.0001 |y Full text (MCPHS users only) |
